Featured Article

2013 Fall – Editorial

In our editorial celebrating the 20th anniversary of the PRO Newsletter in 2011, we wrote: “This special issue shows that since its origins as the “QOL Newsletter,” our biannual publication…

Read More

From Health-Related Quality of Life to Patient-Centered Outcomes: a historical switch to reflect FDA’s efforts in Patient-Focused drug development

By | | No Comments

From Health-Related Quality of Life to Patient-Centered Outcomes: a historical switch to reflect FDA’s efforts in Patient-Focused drug development Authors Professor Donald L. Patrick, Director, Seattle Quality of Life Group and Biobehavioral Cancer Prevention and Training Program, University of Washington, Seattle, Washington,…

Read More